Introduction
Vitamin K is a fat-soluble factor required for hemostasis [1] . The known function of vitamin K is as a cofactor for the posttranslational g-carboxylation of glutamate residues to g-carboxyglutamate (Gla) in certain proteins. Once carboxylated, Gla-proteins are involved in multiple physiological roles, including blood coagulation, bone formation, soft-tissue calcification, cell growth and apoptosis. The aim of this review is to address the role of vitamin K intake in calcification and atherosclerosis.
Matrix g-carboxyglutamic acid and vascular calcification
Vascular calcification is closely linked to the atherosclerosis process and causes a reduction in elasticity of the vessel wall [2] . Vascular smooth-muscle cells have a central role in calcification. They synthesize the vitamin K-dependent protein matrix g-carboxyglutamic acid (MGP), which is an inhibitor of calcification. Deletion of the MGP gene results in rapid calcification of soft tissues, including the arterial media in mice [3] . Reduction of the amount of vitamin K available for normal carboxylation of vitamin K-dependent proteins by using oral anticoagulants, which are vitamin K antagonists, has been associated with increased calcification in rat arteries [4] . Furthermore, it has been shown that supplementation with different forms of vitamin K prevents oral anticoagulant-induced calcification in rats [5, 6 ]. One study suggested that menaquinones, but not phylloquinone, could prevent calcification [5] . The finding was not replicated in a recent study [6 ] , however, in which high doses of phylloquinone and menaquinones were equally efficient in increasing the g-carboxylation of MGP in arterial calcification, and reversing the arterial stiffness observed after oral anticoagulant treatment.
In humans, mutations in the gene encoding MGP, resulting in the production of nonfunctional or absent MGP, are responsible for Keutel syndrome, and are characterized by abnormal cartilage calcification and also calcification of the arteries [7] [8] [9] . MGP has been detected in human atherosclerotic plaques [10] , with the undercarboxylated form present in the calcified regions of the vasculature [11] . Consistent with animal data, use of vitamin K antagonists has been associated with increased calcification in human heart valves [12, 13] and coronary arteries [13] . There is some controversy as to the utility of serum MGP concentrations as a marker of vascular calcification because most published assays do not differentiate between the carboxylated and uncarboxylated form of MGP [14 ] . Furthermore, circulating MGP does not appear to rescue the calcification induced by targeted deletion of MGP in the vessel wall [15] . In the absence of a direct measure of vitamin K status in the vessels of healthy individuals, it is assumed that any dietary role of vitamin K in progression of calcification is mediated through the carboxylation of MGP.
Epidemiological studies: phylloquinone
Whereas the genetic and biochemical studies establish that inadequate carboxylation of MGP results in abnormal calcification, there are limited observational data linking an inadequate intake of phylloquinone with vascular calcification. Dietary intake of phylloquinone, which is the predominant form of vitamin K in the western diet, is primarily from green leafy vegetables and some vegetable oils [16] . Women aged 60-69 years with aortic atherosclerosis reported lower vitamin K intakes than women without calcifications; these findings were not supported among older women (Table 1) [17] . All other studies report no associations between phylloquinone intake and calcification. Among 39-year-old to 45-yearold men and women with relatively low risk of cardiovascular diseases, dietary phylloquinone intake was not associated with coronary artery calcification [18] . Phylloquinone intakes were not associated with calcification of breast arteries [19 ] . The clinical significance of breastartery calcification is controversial, however, because its association with prevalent coronary heart disease (CHD) is weak [20] . Phylloquinone intake was also not associated with the risk of aortic calcification or CHD in men and women aged 55 years or over in the Rotterdam Study (Table 2) [21] . In the Nurses' Health Study [22] and the Health Professionals study [23] , age-adjusted intake of phylloquinone was associated with lower risk of CHD, but, when the dietary and life-style factors affecting CHD risk were adjusted, phylloquinone intake was not significantly associated with CHD risk. The view that phylloquinone intake is a surrogate marker of a heart-healthy diet rather than an independent risk factor was further supported by data from the Framingham Offspring cohort [24] . Intake of vitamin K-rich foods is associated with not only intake of other healthy food items, but also otherwise heart-healthy characteristics, like lower BMI, less smoking, and better serum-lipid profile [22, 24] .
Menaquinones
Menaquinones are a class of vitamin K that differ in structure from phylloquinone in their 3 0 -substituted lipophilic side chain. Similar to phylloquinone, menaquinones can also function as a cofactor for the g-carboxylation of the vitamin K-dependent proteins. Menaquinones are present in the diet, albeit in small quantities, primarily in the form of animal products (meats, eggs, cheese) and in fermented soybeans [16] . Much of the menaquinone-4 in the US diet is found in chicken and chicken products, which can be traced back to the use of menadione in chicken feed [25] . Menadione, a synthetic form of vitamin K, is converted to menaquinone-4 in certain tissues. Phylloquinone is also converted to menaquinone-4 in specific tissues within the organism, the mechanism of which is currently unknown [26 ] . Serum menaquinone concentrations are in nondetectable concentrations in 40 Nutrition and metabolism (Table 2 ) [21] . The intake of menaquinones was estimated based on foodfrequency questionnaires, and was very low compared with that of phylloquinone as estimated in the same population (27-30 mg/day compared with 244-257 mg/day) and compared with current dietary recommendations for vitamin K, which are 90-120 mg/day [27] . As menaquinones are found primarily in animal products, they are not thought to be a marker of a heart-healthy dietary pattern like phylloquinone intake.
Intervention studies
Given that phylloquinone intake is a marker of a hearthealthy diet and assessment of dietary menaquinone intakes is problematic in terms of validation, the role of vitamin K in progression of vascular calcification needs to be assessed in randomized clinical trials. In a 3-year intervention study, the changes in intima-media thickness of carotid arteries were not significantly different among groups of postmenopausal women receiving supplements containing, first, minerals, second, minerals and vitamin D, or, third, minerals, vitamin D and phylloquinone (Table 1 ) [28] . In contrast, the indices of vessel wall reflecting elastic properties were modestly improved by a supplement containing minerals, vitamin D and phylloquinone. To the best of our knowledge, menaquinone supplementation has not been assessed in terms of vascular calcification progression in humans.
Dietary recommendations
The dietary recommendation for vitamin K intake is based on the hepatic requirement to maintain normal hemostasis, and is representative of the median intake in a healthy population [27] . The true requirement based on the role of extra-hepatic vitamin K-dependent proteins is still unknown. It has been argued that the extra-hepatic tissues require more vitamin K for g-carboxylation of Gla-proteins than the current recommendations. Furthermore, some suggest that subclinical vitamin K deficiency is common [29 ] . The data supporting a role of vitamin K intake in the progression of vascular calcification in humans are insufficient, however. In the absence of clinical trials using different forms and doses of vitamin K, it seems premature to recommend supplemental vitamin K.
Conclusion
The roles of phylloquinone and menaquinones in the etiology of vascular diseases in humans remain Vitamin K intake and atherosclerosis Erkkilä and Booth 41 ambiguous. Even though a biologically plausible mechanism is suggested, the data from observational studies refer to a role as a marker for a heart-healthy diet rather than an independent factor in the progress of multifactorial vascular diseases. Studies using biomarkers of vitamin K intake and assessing intake of different forms of vitamin K in relation to cardiovascular diseases are needed to further explore the field.
